Fate Therapeutics Inc
FATE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001434316
In the last 90 days, Fate Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 157 institutions reported holding it in 13F filings for Q2 2026, worth $193.2M in total; no superinvestor holds it.
13F holders, Q3 2026
Institutional positions in Fate Therapeutics Inc as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
Q3 2026 data is still coming in (13F filing deadline: Nov 16, 2026), so these numbers are incomplete.
- Institutional holders
- 101
- −11 vs. Q2 2026
- Shares held
- 41.5M
- +2.40M (+6.1%) vs. Q2 2026
- Total value
- $98.3M
- −$7.15M (−6.8%) vs. Q2 2026
- New holders
- 11
- 19 more added
- Sold out
- 22
- 37 more reduced
45 institutions that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FATE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $193.2M |
| Q1 2026 | 159 | $88.9M |
| Q4 2025 | 147 | $70.9M |
| Q3 2025 | 143 | $101.6M |
| Q2 2025 | 139 | $88.9M |
| Q1 2025 | 132 | $76.3M |
| Q4 2024 | 159 | $166.5M |
| Q3 2024 | 164 | $401.6M |
| Q2 2024 | 182 | $401.1M |
| Q1 2024 | 167 | $904.0M |
| Q4 2023 | 159 | $357.2M |
| Q3 2023 | 171 | $202.9M |
| Q2 2023 | 188 | $519.6M |
| Q1 2023 | 182 | $641.6M |
| Q4 2022 | 228 | $1.07B |
| Q3 2022 | 239 | $2.41B |
| Q2 2022 | 233 | $2.70B |
| Q1 2022 | 249 | $3.92B |
| Q4 2021 | 250 | $5.66B |
| Q3 2021 | 266 | $5.67B |
| Q2 2021 | 272 | $8.20B |
| Q1 2021 | 260 | $7.73B |
Institutions, Q3 2026
Shares, value and share of portfolio for each institution holding Fate Therapeutics Inc; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7,105,172 | $16.8M | 0.00% | −193,723−2.7% | Reduced |
| Vanguard Portfolio Management LLC | 4,959,037 | $11.8M | 0.00% | +413,144+9.1% | Added |
| Acadian Asset Management LLC | 4,765,677 | $11.3M | 0.01% | +414,427+9.5% | Added |
| Vanguard Capital Management LLC | 4,496,086 | $10.7M | 0.00% | +50,550+1.1% | Added |
| Johnson & Johnson | 3,379,064 | $8.01M | 1.05% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 2,374,394 | $5.63M | 0.01% | −608,874−20.4% | Reduced |
| Arrowstreet Capital, Limited Partnership | 2,374,346 | $5.63M | 0.00% | +2,344,170+7,768.3% | Added |
| Qube Research & Technologies Ltd | 1,664,316 | $3.94M | 0.00% | +1,086,166+187.9% | Added |
| Geode Capital Management, LLC | 1,320,456 | $3.13M | 0.00% | −1,557−0.1% | Reduced |
| Assenagon Asset Management S.A. | 1,311,765 | $3.11M | 0.00% | +1,165,927+799.5% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 735,386 | $1.74M | 0.00% | +160,391+27.9% | Added |
| Morgan Stanley | 710,956 | $1.68M | 0.00% | +16,376+2.4% | Added |
| Vanguard Fiduciary Trust Co | 640,428 | $1.52M | 0.00% | 00.0% | Unchanged |
| State Street Corp | 602,128 | $1.43M | 0.00% | +43,200+7.7% | Added |
| Dimensional Fund Advisors LP | 517,313 | $1.23M | 0.00% | +165,087+46.9% | Added |
| Marshall Wace, LLP | 416,938 | $988.1K | 0.00% | −75,488−15.3% | Reduced |
| Privium Fund Management B.V. | 414,311 | $981.9K | 0.19% | 00.0% | Unchanged |
| Invesco Ltd. | 294,342 | $697.6K | 0.00% | +28,360+10.7% | Added |
| Cerity Partners LLC | 288,554 | $683.9K | 0.00% | −53,178−15.6% | Reduced |
| Empowered Funds, LLC | 181,900 | $431.1K | 0.00% | +181,900 | New |
| LPL Financial LLC | 172,746 | $409.4K | 0.00% | −31,000−15.2% | Reduced |
| UBS Group AG | 171,454 | $406.3K | 0.00% | −418,724−70.9% | Reduced |
| Barclays PLC | 155,215 | $367.9K | 0.00% | −32,774−17.4% | Reduced |
| American Century Companies Inc | 153,722 | $364.3K | 0.00% | +74,803+94.8% | Added |
| Squarepoint Ops LLC | 152,247 | $360.8K | 0.00% | −1,377−0.9% | Reduced |
| Arete Wealth Advisors, LLC | 150,000 | $355.5K | 0.02% | 00.0% | Unchanged |
| Catalyst Funds Management Pty Ltd | 127,364 | $301.9K | 0.03% | +127,364 | New |
| Russell Investments Group, Ltd. | 126,492 | $299.8K | 0.00% | +20,690+19.6% | Added |
| Panagora Asset Management Inc | 125,954 | $298.5K | 0.00% | +125,954 | New |
| National Philanthropic Trust | 125,000 | $296.3K | 0.00% | 00.0% | Unchanged |
| Jump Financial, LLC | 124,047 | $294.0K | 0.00% | +124,047 | New |
| Schulhoff & Co Inc | 100,000 | $237.0K | 0.10% | 00.0% | Unchanged |
| Jefferies Financial Group Inc. | 95,600 | $226.6K | 0.00% | +36,478+61.7% | Added |
| BNP Paribas Arbitrage, SA | 75,705 | $179.4K | 0.00% | −195,929−72.1% | Reduced |
| SEI Investments Co | 70,980 | $168.2K | 0.00% | 00.0% | Unchanged |
| EntryPoint Capital, LLC | 56,543 | $134.0K | 0.04% | +56,543 | New |
| Ieq Capital, LLC | 49,330 | $116.9K | 0.00% | −438,398−89.9% | Reduced |
| Hudson Bay Capital Management LP | 47,500 | $112.6K | 0.00% | +22,340+88.8% | Added |
| FMR LLC | 46,857 | $111.1K | 0.00% | −2,219−4.5% | Reduced |
| Y-Intercept (Hong Kong) Ltd | 45,573 | $108.0K | 0.00% | +800+1.8% | Added |
| Vanguard Global Advisers, LLC | 43,754 | $103.7K | 0.00% | −47,957−52.3% | Reduced |
| Aster Capital Management (DIFC) Ltd | 42,584 | $100.9K | 0.04% | −134,016−75.9% | Reduced |
| Spark Investment Management LLC | 42,000 | $99.5K | 0.16% | +42,000 | New |
| Winton Group Ltd | 40,400 | $95.7K | 0.00% | +40,400 | New |
| Abel Hall, LLC | 35,850 | $85.0K | 0.02% | −22−0.1% | Reduced |
| HighTower Advisors, LLC | 32,000 | $75.8K | 0.00% | −1,454−4.3% | Reduced |
| Quantinno Capital Management LP | 28,930 | $68.6K | 0.00% | +28,930 | New |
| Colony Group, LLC | 28,587 | $67.8K | 0.00% | −30,960−52.0% | Reduced |
| FPC Investment Advisory, Inc. | 26,456 | $62.7K | 0.03% | 00.0% | Unchanged |
| Citigroup Inc | 25,199 | $59.7K | 0.00% | +5,569+28.4% | Added |
| Captrust Financial Advisors | 23,317 | $55.3K | 0.00% | −50,295−68.3% | Reduced |
| Creative Planning | 22,699 | $53.8K | 0.00% | −86,281−79.2% | Reduced |
| Theory Financial LLC | 22,222 | $52.7K | 0.02% | 00.0% | Unchanged |
| Bronte Capital Management Pty Ltd. | 21,740 | $51.5K | 0.01% | 00.0% | Unchanged |
| Axq Capital, LP | 20,479 | $48.5K | 0.01% | −20,377−49.9% | Reduced |
| Moneta Group Investment Advisors LLC | 20,245 | $48.0K | 0.00% | +20,245 | New |
| Parametrica Management Ltd | 18,472 | $43.8K | 0.04% | 00.0% | Unchanged |
| Tiaa-Cref Individual & Institutional Services, LLC | 17,592 | $41.7K | 0.00% | 00.0% | Unchanged |
| Ameritas Advisory Services, LLC | 16,000 | $37.9K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 15,158 | $35.9K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 14,526 | $34.4K | 0.00% | −1,012,481−98.6% | Reduced |
| Neuberger Berman Group LLC | 13,688 | $32.4K | 0.00% | −3,008−18.0% | Reduced |
| R Squared Ltd | 13,259 | $31.4K | 0.02% | +137+1.0% | Added |
| Victory Capital Management Inc | 13,039 | $30.9K | 0.00% | +261+2.0% | Added |
| Narwhal Capital Management | 12,700 | $30.1K | 0.00% | 00.0% | Unchanged |
| Wealth Enhancement Advisory Services, LLC | 13,447 | $28.6K | 0.00% | −77,034−85.1% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 12,000 | $28.0K | 0.00% | +12,000 | New |
| Bank of New York Mellon Corp | 11,381 | $27.0K | 0.00% | 00.0% | Unchanged |
| Callan Family Office, LLC | 10,911 | $25.9K | 0.00% | 00.0% | Unchanged |
| Parcion Private Wealth LLC | 10,551 | $25.0K | 0.00% | −11,004−51.1% | Reduced |
| Mariner, LLC | 10,541 | $25.0K | 0.00% | −181,674−94.5% | Reduced |
| Northern Lights Advisors, Inc. | 10,040 | $23.8K | 0.01% | 00.0% | Unchanged |
| Eiger Wealth Management, LLC | 10,000 | $23.7K | 0.51% | 00.0% | Unchanged |
| Allworth Financial LP | 8,676 | $23.4K | 0.00% | 00.0% | Unchanged |
| Westmount Partners, LLC | 10,098 | $23.2K | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 7,816 | $18.5K | 0.00% | −36,506−82.4% | Reduced |
| Rhumbline Advisers | 7,500 | $17.8K | 0.00% | −38,720−83.8% | Reduced |
| Owl Creek Wealth Partners LLC | 4,190 | $9.93K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 2,946 | $6.98K | 0.00% | −1,920−39.5% | Reduced |
| Federated Hermes, Inc. | 2,239 | $5.31K | 0.00% | −776−25.7% | Reduced |
| Nuveen, LLC | 1,885 | $4.56K | 0.00% | +1,885 | New |
| Geneos Wealth Management Inc. | 1,800 | $4.27K | 0.00% | 00.0% | Unchanged |
| GAMMA Investing LLC | 1,467 | $3.48K | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 1,388 | $3.29K | 0.00% | −7,053−83.6% | Reduced |
| UMA Financial Services, Inc. | 1,366 | $3.24K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 1,331 | $3.15K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 1,171 | $2.77K | 0.00% | −1−0.1% | Reduced |
| Valley National Advisers Inc | 1,000 | $2.37K | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 900 | $2.12K | 0.00% | 00.0% | Unchanged |
| Avion Wealth | 858 | $2.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 695 | $1.65K | 0.00% | −8,301−92.3% | Reduced |
| Advisor Group Holdings, Inc. | 585 | $1.39K | 0.00% | −60−9.3% | Reduced |
| Fortitude Family Office, LLC | 427 | $1.01K | 0.00% | −395−48.1% | Reduced |
| The PNC Financial Services Group, Inc. | 314 | $744 | 0.00% | −738−70.2% | Reduced |
| Hilltop National Bank | 285 | $675 | 0.00% | 00.0% | Unchanged |
| Albion Financial Group | 225 | $534 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 116 | $275 | 0.00% | −1,562−93.1% | Reduced |
| Boreal Capital Management LLC | 100 | $237 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 35 | $83 | 0.00% | −985−96.6% | Reduced |
| Smartleaf Asset Management LLC | 35 | $83 | 0.00% | 00.0% | Unchanged |